« Previous
Next »
Journal of Vascular Surgery
Volume 28, Issue 5
, Pages
919-928
, November 1998
Regulation of new blood vessel growth into ischemic skeletal muscle
-
Diagrammatic illustration of the surgical procedure performed on the rabbits. A muscle flap based on the left deep inferior epigastric artery is sutured onto muscle of the right thigh after ligating t
Diagrammatic illustration of the surgical procedure performed on the rabbits. A muscle flap based on the left deep inferior epigastric artery is sutured onto muscle of the right thigh after ligating the right common iliac artery. (Courtesy of Pevec WC, Hendricks D, Rosenthal MS, Shestak KC, Steed DL, Webster MW: Revascularization of an ischemic limb by use of a muscle pedicle flap: A rabbit model. J Vasc Surg 1991;13:385–90.)
-
Histology of vessel density in the muscle-flap region of control and bFGF-treated animals. A, The flap-limb interface of a control animal, 50× magnification (hematoxylin and eosin stain). MicrovesselsHistology of vessel density in the muscle-flap region of control and bFGF-treated animals. A, The flap-limb interface of a control animal, 50× magnification (hematoxylin and eosin stain). Microvessels can be seen, but are scarce and arranged in clusters. B, The flap-limb interface of a bFGF-treated animal, 50× magnification (hematoxylin-eosin stain). The distribution pattern of microvessels is diffuse, and vessel density is increased.
-
Immunohistochemical staining for bFGF at the muscle-flap interface in control and bFGF-treated animals. A, Control tissue, 40× magnification, showing intense pericellular staining with minimal staininImmunohistochemical staining for bFGF at the muscle-flap interface in control and bFGF-treated animals. A, Control tissue, 40× magnification, showing intense pericellular staining with minimal staining in the muscle-flap interface. Brown stain indicates positive reaction for bFGF. B, bFGF-treated tissue, 40× magnification, has both pericellular staining and diffuse extracellular staining throughout the flap-limb interface.
-
Actin and bFGF mRNA expression analyzed by PCR. Lane 1—DNA marker; control animal, lanes 2–5: lane 2—positive control, lane 3—DNAse treated, lane 4—RNAse treated, lane 5—negative control; bFGF-treatedActin and bFGF mRNA expression analyzed by PCR. Lane 1—DNA marker; control animal, lanes 2–5: lane 2—positive control, lane 3—DNAse treated, lane 4—RNAse treated, lane 5—negative control; bFGF-treated animal, lanes 6–9: lane 6—positive control, lane 7—DNAse treated, lane 8—RNAse treated, lane 9—negative control; lane 10—bovine brain. The primer pair used is shown above each panel. Arrow indicates position of correct PCR fragment.
☆ From the Department of Surgery (Drs Bush, Pevec, and Pearson), and the Department of Pathology (Drs Ndoye and Cheung), University of California Medical Center, Davis, and the Department of Molecular Biology (Dr Sasse), Shriners Childrens Hospital, Tampa.
☆☆ Supported in part by the University of California Davis Faculty Research Grant (1996–1997).
★ Reprint requests: William C. Pevec, MD, Department of Surgery, University of California Davis Medical Center, 4301 X Street, Room 2330, Sacramento, CA 95817.
★★ 24/1/91610
PII: S0741-5214(98)70070-9
© 1998 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 28, Issue 5
, Pages
919-928
, November 1998
